RegentAtlantic Capital’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$432K Buy
50,660
+26,734
+112% +$263K 0.01% 477
2022
Q2
$251K Sell
23,926
-29,941
-56% -$328K 0.01% 581
2022
Q1
$586K Sell
53,867
-1,153
-2% -$15.2K 0.02% 424
2021
Q4
$744K Buy
55,020
+13,102
+31% +$175K 0.02% 369
2021
Q3
$568K Sell
41,918
-8,047
-16% -$114K 0.02% 403
2021
Q2
$714K Sell
49,965
-9,844
-16% -$142K 0.02% 344
2021
Q1
$836K Sell
59,809
-574
-1% -$9.36K 0.03% 301
2020
Q4
$1.13M Buy
+60,383
New +$985K 0.04% 229
2015
Q3
Sell
-3,158
Closed -$214K 382
2015
Q2
$214K Buy
+3,158
New +$223K 0.02% 346
2015
Q1
Sell
-3,950
Closed -$223K 946
2014
Q4
$223K Buy
+3,950
New +$212K 0.02% 344
2013
Q4
Sell
-7,610
Closed -$290K 362
2013
Q3
$290K Buy
+7,610
New +$268K 0.03% 291

Other funds holding VTRS

RegentAtlantic Capital's VTRS Position: Q3 2022 in Review

RegentAtlantic Capital increased its Viatris (VTRS) stake by 112% in Q3 2022, buying an estimated $263K and bringing the position to 50,660 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #477.

RegentAtlantic Capital first reported a position in VTRS in Q3 2013 and has held it in 11 quarters since. The position peaked at $1.13M in Q4 2020. 980 funds tracked by Wall St. Rank hold VTRS as of Q3 2022.

  • RegentAtlantic Capital held 50,660 shares of Viatris worth $432K as of Q3 2022.
  • RegentAtlantic Capital bought 26,734 Viatris shares in Q3 2022, an estimated $263K.
  • Viatris made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #477 holding.
  • RegentAtlantic Capital first reported a position in Viatris in Q3 2013 and has held it in 11 quarters since.
  • RegentAtlantic Capital's Viatris position peaked at $1.13M in Q4 2020.
  • 980 funds tracked by Wall St. Rank held Viatris as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.